Short Decsription
Creative Biolabs offers HEK293T-Tg(Human GnRH Receptor) Division-Arrested Cell which GnRH receptor stably expressed in HEK293T cells.
Description
HEK293T-Tg(Human GnRH Receptor) Division-Arrested Cell was engineered to express the receptor human GnRH (NM_000406). This cell line can be used to study GnRH receptor function, signaling pathways, and potential therapeutic interventions. Dividing-arrest cells are cells that are normally kept under specific culture conditions or treated with agents that prevent cell division from being held in a non-dividing state. This can be achieved through methods such as serum starvation, chemical inhibitors of cell cycle progression, or genetic modification.
Features
Well-characterized stable cell lines;
for cell-based high-throughput screening;
Low-cost evaluation of stable cell lines or limited quantities of compounds.
Applications
GnRH receptor function, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
GnRH
Receptor Family
Gonadotrophin-Releasing Hormone
Species
Human
Parental Cell Line
HEK293T
Transfection
Expression vector containing full-length human GNRHR cDNA (GenBank Accession Number NM_000406) with FLAG tag sequence at N-terminus
Gene
NM_000406
Background
Gonadotropin-releasing hormone receptor (GnRHR) is a receptor for gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone- releasing hormone (LHRH) and prolactin release-inhibiting factor (PIF). GnRHR is expressed on the surface of pituitary gonadotrope cells as well as lymphocytes, breast, ovary, and prostate. Gametes and preimplantation embryos also express GnRH and GnRHR. Binding of GnRH to GnRHR causes the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from gonadotropic cells of the anterior pituitary. Mutations in GnRHR may cause hypogonadotropic hypogonadism and may be associated with anosmia.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.